{"transactions":[{"id":683653,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T21:00:12.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":208076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are subject to a restricted stock award granted under the Revelation Biosciences, Inc. 2021 Equity Incentive Plan, with 50% of the shares vesting on the two-year anniversary of the grant date, and the remaining 50% of the shares vesting on the four-year anniversary of the grant date, provided that the Reporting Person remains continuously employed by or provides services to the Company or any subsidiary through the applicable vesting date; and provided, further that such vesting could be accelerated upon the achievement of certain performance milestones."}],"balance_after":422814,"source":{"system":"sec-edgar","filing":"0001193125-26-355663","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526355663/ownership.xml","form_type":"4"}},{"id":795786,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-01T21:32:55.000Z","date":"2026-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":10115,"price":1.13,"value":11429.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the issuer on behalf of the reporting person solely to satisfy required tax withholding obligations arising upon the vesting of restricted stock awards. The transaction was mandatory and the reporting person did not exercise investment discretion with respect to the sale."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.12 to $1.14, inclusive. The reporting person undertakes to provide to Revelation Biosciences, Inc. (REVB), any security holder of REVB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":214738,"source":{"system":"sec-edgar","filing":"0001193125-26-201769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526201769/ownership.xml","form_type":"4"}},{"id":917815,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-05T22:29:45.000Z","date":"2026-02-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":8521,"price":1.86,"value":15849.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All share numbers reflect a 1-for-4 reverse stock split effective January 28, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold by the issuer on behalf of the reporting person solely to satisfy required tax withholding obligations arising upon the vesting of restricted stock awards. The transaction was mandatory and the reporting person did not exercise investment discretion with respect to the sale."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.85 to $1.87, inclusive. The reporting person undertakes to provide to Revelation Biosciences, Inc. (REVB), any security holder of REVB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"All share numbers reflect a 1-for-4 reverse stock split effective January 28, 2026."}],"balance_after":224853,"source":{"system":"sec-edgar","filing":"0001193125-26-039690","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526039690/ownership.xml","form_type":"4"}},{"id":941097,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-12T22:21:07.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":532829,"price":0.9,"value":479546.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted Stock Units under the 2021 Equity Incentive Plan. Vests quarterly over two years from the date of grant."}],"balance_after":933489,"source":{"system":"sec-edgar","filing":"0001193125-26-010648","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526010648/ownership.xml","form_type":"4"}},{"id":1010692,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-31T16:58:15.000Z","date":"2025-10-29","kind":"grant","planned":false,"acquired":true,"shares":390614,"price":1.28,"value":499985.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests quarterly over one year from the grant date."}],"balance_after":400660,"source":{"system":"sec-edgar","filing":"0001193125-25-260423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312525260423/ownership.xml","form_type":"4"}},{"id":1269727,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-13T23:07:18.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":30095,"price":3.87,"value":116467.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on date of grant."}],"balance_after":30137,"source":{"system":"sec-edgar","filing":"0000950170-25-020109","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000095017025020109/ownership.xml","form_type":"4"}},{"id":1987359,"issuer":{"id":8359,"kind":"organization","name":"REVELATION BIOSCIENCES, INC."},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-28T21:08:00.000Z","date":"2023-02-25","kind":"grant","acquired":true,"shares":2542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were granted on 2/25/2022 and  vest 25% on the one-year anniversary of the grant date, and thereafter quarterly over a three-year period, subject to continued service through each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":49,"expiration_date":"2032-02-25","underlying":"Common Stock","underlying_shares":2542},"source":{"system":"sec-edgar","filing":"0001209191-23-013629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810560/000120919123013629/doc4.xml","form_type":"4"}},{"id":3127880,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T16:02:20.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":205,"derivative":{"exercise_price":4.72,"expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":205},"source":{"system":"sec-edgar","filing":"0000920465-20-000081","document":"wf-form4_159112812263735.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000081/wf-form4_159112812263735.xml","form_type":"4"}},{"id":3127879,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-06-02T16:02:20.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":205,"price":4.01,"value":822.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 05/29/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":81771,"source":{"system":"sec-edgar","filing":"0000920465-20-000081","document":"wf-form4_159112812263735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000081/wf-form4_159112812263735.xml","form_type":"4"}},{"id":3143831,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T16:05:15.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":140,"derivative":{"exercise_price":6.89,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":140},"source":{"system":"sec-edgar","filing":"0000920465-20-000074","document":"wf-form4_158991869760750.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000074/wf-form4_158991869760750.xml","form_type":"4"}},{"id":3143830,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-05-19T16:05:15.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":140,"price":5.86,"value":820.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 05/15/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":81566,"source":{"system":"sec-edgar","filing":"0000920465-20-000074","document":"wf-form4_158991869760750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000074/wf-form4_158991869760750.xml","form_type":"4"}},{"id":3164272,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-04T16:09:30.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":133,"derivative":{"exercise_price":7.26,"expiration_date":"2030-04-30","underlying":"Common Stock","underlying_shares":133},"source":{"system":"sec-edgar","filing":"0000920465-20-000065","document":"wf-form4_158862295345946.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000065/wf-form4_158862295345946.xml","form_type":"4"}},{"id":3164271,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-05-04T16:09:30.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":133,"price":6.17,"value":820.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 04/30/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":81426,"source":{"system":"sec-edgar","filing":"0000920465-20-000065","document":"wf-form4_158862295345946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000065/wf-form4_158862295345946.xml","form_type":"4"}},{"id":3174800,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-17T16:02:27.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":146,"derivative":{"exercise_price":6.6,"expiration_date":"2030-04-15","underlying":"Common Stock","underlying_shares":146},"source":{"system":"sec-edgar","filing":"0000920465-20-000048","document":"wf-form4_158715372853613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000048/wf-form4_158715372853613.xml","form_type":"4"}},{"id":3174799,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-04-17T16:02:27.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":146,"price":5.61,"value":819.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 04/15/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":81293,"source":{"system":"sec-edgar","filing":"0000920465-20-000048","document":"wf-form4_158715372853613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000048/wf-form4_158715372853613.xml","form_type":"4"}},{"id":3187569,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-02T18:08:13.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":229,"derivative":{"exercise_price":4.2,"expiration_date":"2030-03-31","underlying":"Common Stock","underlying_shares":229},"source":{"system":"sec-edgar","filing":"0000920465-20-000045","document":"wf-form4_158586527563021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000045/wf-form4_158586527563021.xml","form_type":"4"}},{"id":3187568,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-04-02T18:08:13.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":229,"price":3.57,"value":817.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 03/31/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":81147,"source":{"system":"sec-edgar","filing":"0000920465-20-000045","document":"wf-form4_158586527563021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000045/wf-form4_158586527563021.xml","form_type":"4"}},{"id":3209615,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-16T16:13:23.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":241,"derivative":{"exercise_price":4,"expiration_date":"2030-03-13","underlying":"Common Stock","underlying_shares":241},"source":{"system":"sec-edgar","filing":"0000920465-20-000044","document":"wf-form4_158438958484301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000044/wf-form4_158438958484301.xml","form_type":"4"}},{"id":3209614,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-03-16T16:13:23.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":241,"price":3.4,"value":819.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 03/13/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":80918,"source":{"system":"sec-edgar","filing":"0000920465-20-000044","document":"wf-form4_158438958484301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000044/wf-form4_158438958484301.xml","form_type":"4"}},{"id":3234664,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-03T16:14:25.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":142,"derivative":{"exercise_price":6.8,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":142},"source":{"system":"sec-edgar","filing":"0000920465-20-000039","document":"wf-form4_158327004839858.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000039/wf-form4_158327004839858.xml","form_type":"4"}},{"id":3234663,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-03-03T16:14:25.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":142,"price":5.78,"value":820.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 02/28/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":80677,"source":{"system":"sec-edgar","filing":"0000920465-20-000039","document":"wf-form4_158327004839858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000039/wf-form4_158327004839858.xml","form_type":"4"}},{"id":3264654,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-19T16:47:45.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":115,"derivative":{"exercise_price":8.4,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":115},"source":{"system":"sec-edgar","filing":"0000920465-20-000032","document":"wf-form4_158214884842276.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000032/wf-form4_158214884842276.xml","form_type":"4"}},{"id":3264653,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-02-19T16:47:45.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":115,"price":7.14,"value":821.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 02/14/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":80535,"source":{"system":"sec-edgar","filing":"0000920465-20-000032","document":"wf-form4_158214884842276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000032/wf-form4_158214884842276.xml","form_type":"4"}},{"id":3293039,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-04T16:01:55.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":141,"derivative":{"exercise_price":6.85,"expiration_date":"2030-01-31","underlying":"Common Stock","underlying_shares":141},"source":{"system":"sec-edgar","filing":"0000920465-20-000026","document":"wf-form4_158085009773446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000026/wf-form4_158085009773446.xml","form_type":"4"}},{"id":3293038,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-02-04T16:01:55.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":141,"price":5.82,"value":820.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 01/31/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":80420,"source":{"system":"sec-edgar","filing":"0000920465-20-000026","document":"wf-form4_158085009773446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000026/wf-form4_158085009773446.xml","form_type":"4"}},{"id":3308682,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-17T16:13:48.000Z","date":"2020-01-15","kind":"grant","acquired":true,"shares":692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":692,"derivative":{"exercise_price":7.88,"expiration_date":"2030-01-15","underlying":"Common Stock","underlying_shares":692},"source":{"system":"sec-edgar","filing":"0000920465-20-000022","document":"wf-form4_157929561101622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000022/wf-form4_157929561101622.xml","form_type":"4"}},{"id":3308681,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-17T16:13:48.000Z","date":"2020-01-15","kind":"grant","acquired":true,"shares":692,"price":6.7,"value":4636.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 01/15/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":80279,"source":{"system":"sec-edgar","filing":"0000920465-20-000022","document":"wf-form4_157929561101622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000022/wf-form4_157929561101622.xml","form_type":"4"}},{"id":3312792,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-13T16:19:00.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":30000,"derivative":{"exercise_price":5.25,"expiration_date":"2030-01-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000920465-20-000016","document":"wf-form4_157895032327136.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046520000016/wf-form4_157895032327136.xml","form_type":"4"}},{"id":3366741,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-19T16:12:37.000Z","date":"2019-11-15","kind":"grant","acquired":true,"shares":118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":118,"derivative":{"exercise_price":6.02,"expiration_date":"2029-11-15","underlying":"Common Stock","underlying_shares":118},"source":{"system":"sec-edgar","filing":"0000920465-19-000164","document":"wf-form4_157419794186274.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000164/wf-form4_157419794186274.xml","form_type":"4"}},{"id":3366740,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-11-19T16:12:37.000Z","date":"2019-11-15","kind":"grant","acquired":true,"shares":118,"price":5.12,"value":604.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 11/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":79587,"source":{"system":"sec-edgar","filing":"0000920465-19-000164","document":"wf-form4_157419794186274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000164/wf-form4_157419794186274.xml","form_type":"4"}},{"id":3380852,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-05T16:06:10.000Z","date":"2019-10-31","kind":"grant","acquired":true,"shares":133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":133,"derivative":{"exercise_price":7.02,"expiration_date":"2029-10-31","underlying":"Common Stock","underlying_shares":133},"source":{"system":"sec-edgar","filing":"0000920465-19-000153","document":"wf-form4_157298795551801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000153/wf-form4_157298795551801.xml","form_type":"4"}},{"id":3380851,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-11-05T16:06:10.000Z","date":"2019-10-31","kind":"grant","acquired":true,"shares":133,"price":5.96,"value":792.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 10/31/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":79469,"source":{"system":"sec-edgar","filing":"0000920465-19-000153","document":"wf-form4_157298795551801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000153/wf-form4_157298795551801.xml","form_type":"4"}},{"id":3392422,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-17T17:40:17.000Z","date":"2019-10-15","kind":"grant","acquired":true,"shares":112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":112,"derivative":{"exercise_price":8.38,"expiration_date":"2029-10-15","underlying":"Common Stock","underlying_shares":112},"source":{"system":"sec-edgar","filing":"0000920465-19-000142","document":"wf-form4_157134838523013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000142/wf-form4_157134838523013.xml","form_type":"4"}},{"id":3392421,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-10-17T17:40:17.000Z","date":"2019-10-15","kind":"grant","acquired":true,"shares":112,"price":7.12,"value":797.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 10/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":79336,"source":{"system":"sec-edgar","filing":"0000920465-19-000142","document":"wf-form4_157134838523013.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000142/wf-form4_157134838523013.xml","form_type":"4"}},{"id":3401780,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-02T17:06:12.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":107,"derivative":{"exercise_price":8.8,"expiration_date":"2029-09-30","underlying":"Common Stock","underlying_shares":107},"source":{"system":"sec-edgar","filing":"0000920465-19-000137","document":"wf-form4_157005035002871.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000137/wf-form4_157005035002871.xml","form_type":"4"}},{"id":3401779,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-10-02T17:06:12.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":107,"price":7.48,"value":800.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 09/30/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":79224,"source":{"system":"sec-edgar","filing":"0000920465-19-000137","document":"wf-form4_157005035002871.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000137/wf-form4_157005035002871.xml","form_type":"4"}},{"id":3414332,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-16T19:24:49.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":85,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":85,"derivative":{"exercise_price":10.92,"expiration_date":"2029-09-13","underlying":"Common Stock","underlying_shares":85},"source":{"system":"sec-edgar","filing":"0000920465-19-000129","document":"wf-form4_156867627380306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000129/wf-form4_156867627380306.xml","form_type":"4"}},{"id":3414331,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-09-16T19:24:49.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":85,"price":9.28,"value":788.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 09/13/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":79117,"source":{"system":"sec-edgar","filing":"0000920465-19-000129","document":"wf-form4_156867627380306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000129/wf-form4_156867627380306.xml","form_type":"4"}},{"id":3425242,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-03T16:12:02.000Z","date":"2019-08-30","kind":"grant","acquired":true,"shares":98,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":98,"derivative":{"exercise_price":9.57,"expiration_date":"2029-08-30","underlying":"Common Stock","underlying_shares":98},"source":{"system":"sec-edgar","filing":"0000920465-19-000118","document":"wf-form4_156754150479713.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000118/wf-form4_156754150479713.xml","form_type":"4"}},{"id":3425241,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-09-03T16:12:02.000Z","date":"2019-08-30","kind":"grant","acquired":true,"shares":98,"price":8.13,"value":796.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 08/30/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":79032,"source":{"system":"sec-edgar","filing":"0000920465-19-000118","document":"wf-form4_156754150479713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000118/wf-form4_156754150479713.xml","form_type":"4"}},{"id":3436739,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-16T16:51:20.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":99,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":99,"derivative":{"exercise_price":9.43,"expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":99},"source":{"system":"sec-edgar","filing":"0000920465-19-000112","document":"wf-form4_156598866484777.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000112/wf-form4_156598866484777.xml","form_type":"4"}},{"id":3436738,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-08-16T16:51:20.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":99,"price":8.02,"value":793.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 08/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":78934,"source":{"system":"sec-edgar","filing":"0000920465-19-000112","document":"wf-form4_156598866484777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000112/wf-form4_156598866484777.xml","form_type":"4"}},{"id":3449905,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-02T16:59:00.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":112,"derivative":{"exercise_price":8.36,"expiration_date":"2029-07-31","underlying":"Common Stock","underlying_shares":112},"source":{"system":"sec-edgar","filing":"0000920465-19-000102","document":"wf-form4_156477951762022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000102/wf-form4_156477951762022.xml","form_type":"4"}},{"id":3449904,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-08-02T16:59:00.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":112,"price":7.11,"value":796.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 07/31/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":78835,"source":{"system":"sec-edgar","filing":"0000920465-19-000102","document":"wf-form4_156477951762022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000102/wf-form4_156477951762022.xml","form_type":"4"}},{"id":3460284,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-17T17:10:27.000Z","date":"2019-07-15","kind":"grant","acquired":true,"shares":102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":102,"derivative":{"exercise_price":9.24,"expiration_date":"2029-07-15","underlying":"Common Stock","underlying_shares":102},"source":{"system":"sec-edgar","filing":"0000920465-19-000096","document":"wf-form4_156339781200245.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000096/wf-form4_156339781200245.xml","form_type":"4"}},{"id":3460283,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-07-17T17:10:27.000Z","date":"2019-07-15","kind":"grant","acquired":true,"shares":102,"price":7.85,"value":800.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 07/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":78723,"source":{"system":"sec-edgar","filing":"0000920465-19-000096","document":"wf-form4_156339781200245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000096/wf-form4_156339781200245.xml","form_type":"4"}},{"id":3475175,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-01T18:11:46.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":101,"derivative":{"exercise_price":9.25,"expiration_date":"2029-06-28","underlying":"Common Stock","underlying_shares":101},"source":{"system":"sec-edgar","filing":"0000920465-19-000093","document":"wf-form4_156201909175001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000093/wf-form4_156201909175001.xml","form_type":"4"}},{"id":3475174,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-07-01T18:11:46.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":101,"price":7.86,"value":793.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 06/28/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":78621,"source":{"system":"sec-edgar","filing":"0000920465-19-000093","document":"wf-form4_156201909175001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000093/wf-form4_156201909175001.xml","form_type":"4"}},{"id":3486798,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-18T16:44:33.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":96,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":96,"derivative":{"exercise_price":9.71,"expiration_date":"2029-06-14","underlying":"Common Stock","underlying_shares":96},"source":{"system":"sec-edgar","filing":"0000920465-19-000088","document":"wf-form4_156089065536215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000088/wf-form4_156089065536215.xml","form_type":"4"}},{"id":3486797,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-18T16:44:33.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":96,"price":8.25,"value":792.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 06/14/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":78520,"source":{"system":"sec-edgar","filing":"0000920465-19-000088","document":"wf-form4_156089065536215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000088/wf-form4_156089065536215.xml","form_type":"4"}},{"id":3505497,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-03T19:27:23.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":174,"derivative":{"exercise_price":5.39,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":174},"source":{"system":"sec-edgar","filing":"0000920465-19-000085","document":"wf-form4_155960442896347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000085/wf-form4_155960442896347.xml","form_type":"4"}},{"id":3505496,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-03T19:27:23.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":174,"price":4.58,"value":796.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 05/31/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":78424,"source":{"system":"sec-edgar","filing":"0000920465-19-000085","document":"wf-form4_155960442896347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000085/wf-form4_155960442896347.xml","form_type":"4"}},{"id":3522205,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-17T16:07:46.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":143,"derivative":{"exercise_price":6.57,"expiration_date":"2029-05-15","underlying":"Common Stock","underlying_shares":143},"source":{"system":"sec-edgar","filing":"0000920465-19-000082","document":"wf-form4_155812365217045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000082/wf-form4_155812365217045.xml","form_type":"4"}},{"id":3522204,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-05-17T16:07:46.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":143,"price":5.58,"value":797.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 05/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":78250,"source":{"system":"sec-edgar","filing":"0000920465-19-000082","document":"wf-form4_155812365217045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000082/wf-form4_155812365217045.xml","form_type":"4"}},{"id":3542923,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-02T17:11:40.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":116,"derivative":{"exercise_price":8.05,"expiration_date":"2029-04-30","underlying":"Common Stock","underlying_shares":116},"source":{"system":"sec-edgar","filing":"0000920465-19-000070","document":"wf-form4_155683148488722.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000070/wf-form4_155683148488722.xml","form_type":"4"}},{"id":3542922,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-05-02T17:11:40.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":116,"price":6.84,"value":793.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 04/30/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":78107,"source":{"system":"sec-edgar","filing":"0000920465-19-000070","document":"wf-form4_155683148488722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000070/wf-form4_155683148488722.xml","form_type":"4"}},{"id":3554458,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-17T17:01:45.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":131,"derivative":{"exercise_price":7.16,"expiration_date":"2029-04-15","underlying":"Common Stock","underlying_shares":131},"source":{"system":"sec-edgar","filing":"0000920465-19-000060","document":"wf-form4_155553489129499.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000060/wf-form4_155553489129499.xml","form_type":"4"}},{"id":3554457,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-04-17T17:01:45.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":131,"price":6.09,"value":797.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 04/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":77991,"source":{"system":"sec-edgar","filing":"0000920465-19-000060","document":"wf-form4_155553489129499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000060/wf-form4_155553489129499.xml","form_type":"4"}},{"id":3570177,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-02T19:08:36.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":146,"derivative":{"exercise_price":6.43,"expiration_date":"2029-03-29","underlying":"Common Stock","underlying_shares":146},"source":{"system":"sec-edgar","filing":"0000920465-19-000059","document":"wf-form4_155424649942485.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000059/wf-form4_155424649942485.xml","form_type":"4"}},{"id":3570176,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-04-02T19:08:36.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":146,"price":5.47,"value":798.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 03/29/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":77860,"source":{"system":"sec-edgar","filing":"0000920465-19-000059","document":"wf-form4_155424649942485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000059/wf-form4_155424649942485.xml","form_type":"4"}},{"id":3588951,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-19T17:07:40.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":122,"derivative":{"exercise_price":7.64,"expiration_date":"2029-03-15","underlying":"Common Stock","underlying_shares":122},"source":{"system":"sec-edgar","filing":"0000920465-19-000054","document":"wf-form4_155302964495361.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000054/wf-form4_155302964495361.xml","form_type":"4"}},{"id":3588950,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-03-19T17:07:40.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":122,"price":6.49,"value":791.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 3/15/19 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":77714,"source":{"system":"sec-edgar","filing":"0000920465-19-000054","document":"wf-form4_155302964495361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000054/wf-form4_155302964495361.xml","form_type":"4"}},{"id":3620680,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-04T17:32:42.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":164,"derivative":{"exercise_price":5.7,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":164},"source":{"system":"sec-edgar","filing":"0000920465-19-000048","document":"wf-form4_155173874836801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000048/wf-form4_155173874836801.xml","form_type":"4"}},{"id":3620679,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-03-04T17:32:42.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":164,"price":4.85,"value":795.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 02/28/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":77592,"source":{"system":"sec-edgar","filing":"0000920465-19-000048","document":"wf-form4_155173874836801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000048/wf-form4_155173874836801.xml","form_type":"4"}},{"id":3651143,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-19T18:10:10.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":151,"derivative":{"exercise_price":6.23,"expiration_date":"2029-02-15","underlying":"Common Stock","underlying_shares":151},"source":{"system":"sec-edgar","filing":"0000920465-19-000033","document":"wf-form4_155061779659395.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000033/wf-form4_155061779659395.xml","form_type":"4"}},{"id":3651142,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-02-19T18:10:10.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":151,"price":5.3,"value":800.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 02/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":77428,"source":{"system":"sec-edgar","filing":"0000920465-19-000033","document":"wf-form4_155061779659395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000033/wf-form4_155061779659395.xml","form_type":"4"}},{"id":3678420,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-04T18:12:40.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":155,"derivative":{"exercise_price":6.04,"expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":155},"source":{"system":"sec-edgar","filing":"0000920465-19-000027","document":"wf-form4_154932194623724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000027/wf-form4_154932194623724.xml","form_type":"4"}},{"id":3678419,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-02-04T18:12:40.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":155,"price":5.13,"value":795.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 01/31/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":77277,"source":{"system":"sec-edgar","filing":"0000920465-19-000027","document":"wf-form4_154932194623724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000027/wf-form4_154932194623724.xml","form_type":"4"}},{"id":3687281,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-25T21:58:47.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":53000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":53000,"derivative":{"exercise_price":5.99,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":53000},"source":{"system":"sec-edgar","filing":"0000920465-19-000021","document":"wf-form4_154847151000338.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000021/wf-form4_154847151000338.xml","form_type":"4"}},{"id":3693939,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-17T20:52:58.000Z","date":"2019-01-15","kind":"grant","acquired":true,"shares":792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":792,"derivative":{"exercise_price":6.75,"expiration_date":"2029-01-15","underlying":"Common Stock","underlying_shares":792},"source":{"system":"sec-edgar","filing":"0000920465-19-000013","document":"wf-form4_154777636252580.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000013/wf-form4_154777636252580.xml","form_type":"4"}},{"id":3693938,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-01-17T20:52:58.000Z","date":"2019-01-15","kind":"grant","acquired":true,"shares":792,"price":5.74,"value":4546.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 01/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":77122,"source":{"system":"sec-edgar","filing":"0000920465-19-000013","document":"wf-form4_154777636252580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000013/wf-form4_154777636252580.xml","form_type":"4"}},{"id":3699396,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-01-09T21:28:48.000Z","date":"2019-01-09","kind":"purchase","acquired":true,"shares":800,"price":6.1,"value":4880.0,"ownership":{"direct":true},"balance_after":76330,"source":{"system":"sec-edgar","filing":"0000920465-19-000009","document":"wf-form4_154708731010561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000009/wf-form4_154708731010561.xml","form_type":"4"}},{"id":3699395,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-01-09T21:28:48.000Z","date":"2019-01-09","kind":"purchase","acquired":true,"shares":500,"price":6.09,"value":3045.0,"ownership":{"direct":true},"balance_after":75530,"source":{"system":"sec-edgar","filing":"0000920465-19-000009","document":"wf-form4_154708731010561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000009/wf-form4_154708731010561.xml","form_type":"4"}},{"id":3699394,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-01-09T21:28:48.000Z","date":"2019-01-09","kind":"purchase","acquired":true,"shares":300,"price":6.07,"value":1821.0,"ownership":{"direct":true},"balance_after":75030,"source":{"system":"sec-edgar","filing":"0000920465-19-000009","document":"wf-form4_154708731010561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000009/wf-form4_154708731010561.xml","form_type":"4"}},{"id":3710599,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-03T19:53:05.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":97,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":97,"derivative":{"exercise_price":9.43,"expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":97},"source":{"system":"sec-edgar","filing":"0000920465-19-000004","document":"wf-form4_154656316791962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000004/wf-form4_154656316791962.xml","form_type":"4"}},{"id":3710598,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-01-03T19:53:05.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":97,"price":8.0155,"value":777.5035,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 12/31/2018 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":74730,"source":{"system":"sec-edgar","filing":"0000920465-19-000004","document":"wf-form4_154656316791962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046519000004/wf-form4_154656316791962.xml","form_type":"4"}},{"id":3729839,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-17T20:28:27.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":70,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":70,"derivative":{"exercise_price":12.8,"expiration_date":"2028-12-14","underlying":"Common Stock","underlying_shares":70},"source":{"system":"sec-edgar","filing":"0000920465-18-000066","document":"wf-form4_154509649121941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000066/wf-form4_154509649121941.xml","form_type":"4"}},{"id":3729838,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-12-17T20:28:27.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":70,"price":10.88,"value":761.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 12/14/2018 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":74633,"source":{"system":"sec-edgar","filing":"0000920465-18-000066","document":"wf-form4_154509649121941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000066/wf-form4_154509649121941.xml","form_type":"4"}},{"id":3746666,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-03T21:56:51.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":63,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":63,"derivative":{"exercise_price":14.47,"expiration_date":"2028-11-30","underlying":"Common Stock","underlying_shares":63},"source":{"system":"sec-edgar","filing":"0000920465-18-000063","document":"wf-form4_154389219522178.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000063/wf-form4_154389219522178.xml","form_type":"4"}},{"id":3746665,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-12-03T21:56:51.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":63,"price":12.2995,"value":774.8685,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 11/30/2018 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":74563,"source":{"system":"sec-edgar","filing":"0000920465-18-000063","document":"wf-form4_154389219522178.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000063/wf-form4_154389219522178.xml","form_type":"4"}},{"id":3759781,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-19T17:06:14.000Z","date":"2018-11-15","kind":"grant","acquired":true,"shares":61,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":61,"derivative":{"exercise_price":14.9,"expiration_date":"2028-11-15","underlying":"Common Stock","underlying_shares":61},"source":{"system":"sec-edgar","filing":"0000920465-18-000058","document":"wf-form4_154266515545312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000058/wf-form4_154266515545312.xml","form_type":"4"}},{"id":3759780,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-11-19T17:06:14.000Z","date":"2018-11-15","kind":"grant","acquired":true,"shares":61,"price":12.665,"value":772.565,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 11/15/2018 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":74500,"source":{"system":"sec-edgar","filing":"0000920465-18-000058","document":"wf-form4_154266515545312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000058/wf-form4_154266515545312.xml","form_type":"4"}},{"id":3778436,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-01T20:43:20.000Z","date":"2018-10-31","kind":"grant","acquired":true,"shares":56,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":56,"derivative":{"exercise_price":16.3,"expiration_date":"2028-10-31","underlying":"Common Stock","underlying_shares":56},"source":{"system":"sec-edgar","filing":"0000920465-18-000054","document":"wf-form4_154111938406283.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000054/wf-form4_154111938406283.xml","form_type":"4"}},{"id":3778435,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-11-01T20:43:20.000Z","date":"2018-10-31","kind":"grant","acquired":true,"shares":56,"price":13.855,"value":775.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 10/31/2018 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":74439,"source":{"system":"sec-edgar","filing":"0000920465-18-000054","document":"wf-form4_154111938406283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000054/wf-form4_154111938406283.xml","form_type":"4"}},{"id":3791395,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-15T20:52:38.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":55,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":55,"derivative":{"exercise_price":16.25,"expiration_date":"2028-10-15","underlying":"Common Stock","underlying_shares":55},"source":{"system":"sec-edgar","filing":"0000920465-18-000041","document":"wf-form4_153965114297732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000041/wf-form4_153965114297732.xml","form_type":"4"}},{"id":3791394,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-10-15T20:52:38.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":55,"price":13.81,"value":759.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired on 10/15/2018 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":74383,"source":{"system":"sec-edgar","filing":"0000920465-18-000041","document":"wf-form4_153965114297732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000041/wf-form4_153965114297732.xml","form_type":"4"}},{"id":3838848,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-08-20T21:06:18.000Z","date":"2018-08-16","kind":"purchase","acquired":true,"shares":1000,"price":21.997,"value":21997.0,"ownership":{"direct":true},"balance_after":74328,"source":{"system":"sec-edgar","filing":"0000920465-18-000029","document":"wf-form4_153481356291910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046518000029/wf-form4_153481356291910.xml","form_type":"4"}},{"id":4119333,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-29T17:03:48.000Z","date":"2017-12-27","kind":"grant","acquired":true,"shares":6700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":6700,"derivative":{"exercise_price":32.47,"expiration_date":"2027-12-27","underlying":"Common Stock","underlying_shares":6700},"source":{"system":"sec-edgar","filing":"0000920465-17-000088","document":"wf-form4_151458501364470.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046517000088/wf-form4_151458501364470.xml","form_type":"4"}},{"id":4133862,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-13T21:06:31.000Z","date":"2017-12-11","kind":"grant","acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years."}],"balance_after":49000,"derivative":{"exercise_price":28.1,"expiration_date":"2027-12-11","underlying":"Common Stock","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0000920465-17-000080","document":"wf-form4_151321717647244.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046517000080/wf-form4_151321717647244.xml","form_type":"4"}},{"id":4496926,"issuer":{"id":124310,"kind":"organization","name":"LA JOLLA PHARMACEUTICAL CO","symbol":"LJPC"},"owners":[{"id":22278,"kind":"person","name":"Rolke James","position":1,"cik":"0001693858","reported_name":"Rolke James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-06T18:22:03.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":64100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 64,100 shares of the Issuer's Common Stock one quarter of which shall be fully vested and exercisable on January 4, 2018, with the remaining 48,075 shares vesting monthly thereafter over the next three years."}],"balance_after":64100,"derivative":{"exercise_price":19.19,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":64100},"source":{"system":"sec-edgar","filing":"0000920465-17-000012","document":"wf-form4_148374491099675.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/920465/000092046517000012/wf-form4_148374491099675.xml","form_type":"4"}}]}